Back to Agenda
Session 3: Early Dialogue Between Regulators and HTA (and Payers & Patients)
Speaker(s)
HTA Bodies Cooperation on Early Dialogues: Recent Advances
François Meyer, MD
French National Authority for Health (HAS), France
Advisor to the President, International Affairs
Enhancing the Dialogue Beyond RCTs
Byron Jones
Statistical Methodology and Consulting Group, Novartis Pharma AG, Switzerland
Executive Director
The Imperfect Study Design – How to Deal with It?
Stefan Lange, MD
Institute for Quality and Efficiency in Health Care (IQWiG), Germany
Deputy Director
Have an account?